47 min
Vaccine Innovation & The Future of Clinical Trials Post Covid-19 HEALTHCAST - A CMHS@IIMA PODCAST SERIES
-
- Education
Dr. Mehul Mehta, CMO, Albright Stonebridge Group & Visiting Faculty in Ophthalmology and Global Health at Harvard Medical School talks about Vaccine Innovation & The Future of Clinical Trials Post Covid-19. The session was moderated by IIMA Prof. Chirantan Chatterjee.
Dr. Mehul Mehta, CMO, Albright Stonebridge Group & Visiting Faculty in Ophthalmology and Global Health at Harvard Medical School talks about Vaccine Innovation & The Future of Clinical Trials Post Covid-19. The session was moderated by IIMA Prof. Chirantan Chatterjee.
47 min